Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20681678rdf:typepubmed:Citationlld:pubmed
pubmed-article:20681678lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:20681678lifeskim:mentionsumls-concept:C0567416lld:lifeskim
pubmed-article:20681678lifeskim:mentionsumls-concept:C0030685lld:lifeskim
pubmed-article:20681678lifeskim:mentionsumls-concept:C0024488lld:lifeskim
pubmed-article:20681678lifeskim:mentionsumls-concept:C0563532lld:lifeskim
pubmed-article:20681678lifeskim:mentionsumls-concept:C0680255lld:lifeskim
pubmed-article:20681678lifeskim:mentionsumls-concept:C1450054lld:lifeskim
pubmed-article:20681678lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:20681678lifeskim:mentionsumls-concept:C0391871lld:lifeskim
pubmed-article:20681678lifeskim:mentionsumls-concept:C1283071lld:lifeskim
pubmed-article:20681678lifeskim:mentionsumls-concept:C1963578lld:lifeskim
pubmed-article:20681678pubmed:issue31lld:pubmed
pubmed-article:20681678pubmed:dateCreated2010-8-4lld:pubmed
pubmed-article:20681678pubmed:abstractTextMesoporous silica nanoparticles are useful nanomaterials that have demonstrated the ability to contain and release cargos with mediation by gatekeepers. Magnetic nanocrystals have the ability to exhibit hyperthermic effects when placed in an oscillating magnetic field. In a system combining these two materials and a thermally sensitive gatekeeper, a unique drug delivery system can be produced. A novel material that incorporates zinc-doped iron oxide nanocrystals within a mesoporous silica framework that has been surface-modified with pseudorotaxanes is described. Upon application of an AC magnetic field, the nanocrystals generate local internal heating, causing the molecular machines to disassemble and allowing the cargos (drugs) to be released. When breast cancer cells (MDA-MB-231) were treated with doxorubicin-loaded particles and exposed to an AC field, cell death occurred. This material promises to be a noninvasive, externally controlled drug delivery system with cancer-killing properties.lld:pubmed
pubmed-article:20681678pubmed:languageenglld:pubmed
pubmed-article:20681678pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20681678pubmed:citationSubsetIMlld:pubmed
pubmed-article:20681678pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20681678pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20681678pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20681678pubmed:statusMEDLINElld:pubmed
pubmed-article:20681678pubmed:monthAuglld:pubmed
pubmed-article:20681678pubmed:issn1520-5126lld:pubmed
pubmed-article:20681678pubmed:authorpubmed-author:CheonJinwooJlld:pubmed
pubmed-article:20681678pubmed:authorpubmed-author:ChoiEunjooElld:pubmed
pubmed-article:20681678pubmed:authorpubmed-author:StoddartJ...lld:pubmed
pubmed-article:20681678pubmed:authorpubmed-author:ZinkJeffrey...lld:pubmed
pubmed-article:20681678pubmed:authorpubmed-author:ShinJeon-SooJ...lld:pubmed
pubmed-article:20681678pubmed:authorpubmed-author:LeeJae-HyunJHlld:pubmed
pubmed-article:20681678pubmed:authorpubmed-author:KimEun SookESlld:pubmed
pubmed-article:20681678pubmed:authorpubmed-author:FerrisDaniel...lld:pubmed
pubmed-article:20681678pubmed:authorpubmed-author:ChoMi HyeonMHlld:pubmed
pubmed-article:20681678pubmed:authorpubmed-author:ThomasCourtne...lld:pubmed
pubmed-article:20681678pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20681678pubmed:day11lld:pubmed
pubmed-article:20681678pubmed:volume132lld:pubmed
pubmed-article:20681678pubmed:ownerNLMlld:pubmed
pubmed-article:20681678pubmed:authorsCompleteYlld:pubmed
pubmed-article:20681678pubmed:pagination10623-5lld:pubmed
pubmed-article:20681678pubmed:meshHeadingpubmed-meshheading:20681678...lld:pubmed
pubmed-article:20681678pubmed:meshHeadingpubmed-meshheading:20681678...lld:pubmed
pubmed-article:20681678pubmed:meshHeadingpubmed-meshheading:20681678...lld:pubmed
pubmed-article:20681678pubmed:meshHeadingpubmed-meshheading:20681678...lld:pubmed
pubmed-article:20681678pubmed:meshHeadingpubmed-meshheading:20681678...lld:pubmed
pubmed-article:20681678pubmed:meshHeadingpubmed-meshheading:20681678...lld:pubmed
pubmed-article:20681678pubmed:meshHeadingpubmed-meshheading:20681678...lld:pubmed
pubmed-article:20681678pubmed:meshHeadingpubmed-meshheading:20681678...lld:pubmed
pubmed-article:20681678pubmed:meshHeadingpubmed-meshheading:20681678...lld:pubmed
pubmed-article:20681678pubmed:meshHeadingpubmed-meshheading:20681678...lld:pubmed
pubmed-article:20681678pubmed:meshHeadingpubmed-meshheading:20681678...lld:pubmed
pubmed-article:20681678pubmed:meshHeadingpubmed-meshheading:20681678...lld:pubmed
pubmed-article:20681678pubmed:year2010lld:pubmed
pubmed-article:20681678pubmed:articleTitleNoninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles.lld:pubmed
pubmed-article:20681678pubmed:affiliationDepartment of Chemistry and Biochemistry, University of California, Los Angeles, California 90095-1569, USA.lld:pubmed
pubmed-article:20681678pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20681678pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:20681678pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed